Functionally, HMGCL overexpression alleviated the effects of TGF-β1 on BPH-1 cells, as indicated by changes in proliferation, expressions of EMT markers, and the Wnt/β-catenin pathway. This evidence concerns the gene HMGCL and benign prostatic hyperplasia.